ヌクレオチドの市場規模、シェア、成長分析：製品タイプ別、テクノロジー別、形態別、用途別、地域別 - 産業予測 2025～2032年

ヌクレオチド市場規模は2023年に6億8,820万米ドルとなり、2024年の7億3,844万米ドルから2032年には12億9,751万米ドルに成長し、予測期間（2025～2032年）のCAGRは7.3%で成長する見通しです。

世界のヌクレオチド市場は、医薬品、飲食品、動物飼料、診断研究など、その用途の広がりによって、大きな成長を遂げるものと思われます。特定の風味増強剤の悪影響に対する消費者の意識の高まりが、特に北米においてヌクレオチドベースの代替品への需要を高めています。特に米国とカナダの製薬セクターでは、企業がヌクレオチドの革新的な用途を模索しているため、大幅な拡大が見られます。さらに、畜産業界では動物の健康への関心が高まっており、ヌクレオチドを強化した食品添加物の必要性が高まっています。さらに、病気、ウイルス感染、がんの検出を促進する診断研究におけるヌクレオチドの使用増加が、今後数年間の需要増加をさらに後押ししています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

ヌクレオチド市場規模：製品タイプ別

• 市場概要
• 食品グレード
• ラボグレード
• 産業グレード
• その他

ヌクレオチド市場規模：テクノロジー別

• 市場概要
• TaqMan対立遺伝子識別
• 遺伝子チップとマイクロアレイ
• パイロシークエンスによるSNP
• その他

ヌクレオチド市場規模：形態別

• 市場概要
• 液体
• 粉

ヌクレオチド市場規模：用途別

• 市場概要
• 創薬
• 食品および動物飼料添加物
• 製薬
• その他

ヌクレオチド市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Ajinomoto Co., Inc.（Japan）
• CJ CheilJedang Corp.（South Korea）
• STAR LAKE BIOSCIENCE（China）
• Thermo Fisher Scientific Inc.（USA）
• DAESANG（South Korea）
• Agilent Technologies, Inc.（USA）
• Lonza Group Ltd.（Switzerland）
• Meihua Holdings Group Co., Ltd.（China）
• Shandong Ruihong Biotechnology Co., Ltd.（China）
• Koninklijke DSM N.V.（Netherlands）
• Sanofi（France）
• Evonik Industries AG（Germany）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• BASF SE（Germany）
• Lallemand Inc.（Canada）
• Affymetrix Inc.（USA）
• Ohly GmbH（Germany）
• Nanjing Bio Together Co., Ltd.（China）
• PR omega Corporation（USA）
• Biorigin（Brazil）

結論と提言

Nucleotide Market size was valued at USD 688.2 million in 2023 and is poised to grow from USD 738.44 million in 2024 to USD 1297.51 million by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The global nucleotide market is set to experience significant growth, driven by its broadening applications across pharmaceuticals, food and beverages, animal feed, and diagnostic research. Rising consumer awareness of the negative effects of certain flavor enhancers has heightened demand for nucleotide-based alternatives, particularly in North America. The pharmaceutical sector, especially in the U.S. and Canada, is witnessing substantial expansion as companies explore innovative uses for nucleotides. Additionally, the livestock industry's growing focus on animal health is fueling the need for nucleotide-enhanced food additives. Moreover, the increasing use of nucleotides in diagnostic research-facilitating the detection of diseases, viral infections, and cancers-further supports this upward trajectory in demand over the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nucleotide market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nucleotide Market Segments Analysis

Global Nucleotide Market is segmented by Product Type, Technology, Form, Application and region. Based on Product Type, the market is segmented into Food Grade, Lab Grade, Industry Grade and Others. Based on Technology, the market is segmented into TaqMan Allelic Discrimination, Gene Chips and Microarrays, SNP by Pyrosequencing and Others. Based on Form, the market is segmented into Liquid and Powder. Based on Application, the market is segmented into Drug Discovery, Food & Animal Feed Additives, Pharmaceutical and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nucleotide Market

The global nucleotide market is significantly influenced by ongoing innovations in pharmaceutical research and development. Nucleotides are essential components in drug discovery, gene therapies, and the advancement of personalized medicine, which collectively fuel their increasing demand within the pharmaceutical sector. As researchers explore new therapeutic approaches and better treatment options, the reliance on nucleotides for their critical functions in cellular processes and genetic material becomes increasingly important. This continuous evolution in the field reinforces the pivotal role of nucleotides, ensuring their sustained presence and growth in both clinical applications and pharmaceutical development strategies, thereby propelling the overall market forward.

Restraints in the Nucleotide Market

The nucleotide market faces significant restraints primarily due to the high production costs associated with their complex synthesis processes. These intricate procedures necessitate advanced technology and materials, making nucleotides less accessible for various applications and regions. As a result, their elevated pricing can restrict adoption in industries where cost efficiency is vital, limiting their utilization in certain territories. Consequently, this financial barrier hinders broader market penetration and adoption, posing a challenge for manufacturers and stakeholders aiming to expand the range of applications for nucleotides. Overall, the combination of high production costs and the need for specialized techniques significantly impacts the market's growth potential.

Market Trends of the Nucleotide Market

The nucleotide market is witnessing a significant trend driven by consumer demand for natural and clean-label ingredients. As health-conscious consumers increasingly seek products that align with their lifestyle choices, manufacturers are responding by sourcing nucleotides from sustainable and organic origins. This shift towards natural ingredients not only enhances product appeal but also aligns with the broader trend of transparency in food labeling. Companies are investing in research and development to explore innovative extraction methods and establish ethical supply chains, which will ultimately strengthen their market position. As this trend continues, the nucleotide market is likely to expand, catering to the growing preference for clean-label products.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Nucleotide Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Food Grade
• Lab Grade
• Industry Grade
• Others

Global Nucleotide Market Size by Technology & CAGR (2025-2032)

• Market Overview
• TaqMan Allelic Discrimination
• Gene Chips and Microarrays
• SNP by Pyrosequencing
• Others

Global Nucleotide Market Size by Form & CAGR (2025-2032)

• Market Overview
• Liquid
• Powder

Global Nucleotide Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Food & Animal Feed Additives
• Pharmaceutical
• Others

Global Nucleotide Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Form, Application)
  • US
  • Canada
• Europe (Product Type, Technology, Form, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Form, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Form, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Form, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Ajinomoto Co., Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CJ CheilJedang Corp. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STAR LAKE BIOSCIENCE (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DAESANG (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meihua Holdings Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Ruihong Biotechnology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke DSM N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ohly GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanjing Bio Together Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PR omega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biorigin (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations